Dr Roberto Borea explores how BMI impacts NSCLC survival and molecular pathways, revealing key T-cell and redox data for IO and TKI treatment cohorts.
Roberto Borea, MD
Roberto Borea, MD, is a Research Assistant Professor within the Division of Medical Oncology at The Ohio State University.
Articles by Roberto Borea, MD